Many studies have evaluated the circulating levels of GAS5 in plasma or serum from cancer patients and the promising results obtained in this field make circulating GAS5 a potentially interesting non-invasive tool for cancer diagnosis, prognosis, and treatment response. The gene discussed is GAS5; the disease is cancer.